Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10852515 | Biologicals | 2016 | 10 Pages |
Abstract
The review concludes that whilst prudent switching practices should be employed, growing safety experience accumulated thus far with CT-P13 and other biosimilars is favorable and does not raise any specific concerns.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biochemistry, Genetics and Molecular Biology (General)
Authors
Jürgen Braun, Alex Kudrin,